Gsk Plc ADR (GSK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Sales | 9,119,532 | 9,472,118 | 9,440,224 | 11,235,000 | 10,517,760 |
| Cost of Goods | 3,056,250 | 2,898,120 | 2,885,010 | 4,062,260 | 3,272,050 |
| Gross Profit | 6,378,200 | 6,461,030 | 6,405,620 | 7,101,699 | 6,818,450 |
| Operating Expenses | 4,705,780 | 4,820,220 | 4,757,040 | 3,503,920 | 4,532,250 |
| Operating Income | 1,357,752 | 1,753,898 | 1,798,184 | 3,669,080 | 2,713,510 |
| Interest Expense | 299,100 | 297,890 | 301,240 | 601,520 | 296,050 |
| Other Income | -142,952 | 203,422 | -2,304 | 989,669 | -244,360 |
| Pre-tax Income | 915,700 | 1,659,430 | 1,494,640 | 4,057,229 | 2,173,100 |
| Income Tax | 272,370 | 477,970 | 304,550 | 80,040 | 607,600 |
| Net Income Continuous | 647,703 | 1,113,966 | 1,123,476 | 3,924,000 | 1,565,546 |
| Net Income | $647,703 | $1,113,966 | $1,123,476 | $3,924,000 | $1,565,546 |
| EPS Basic Total Ops | 0.34 | 0.58 | 0.59 | 2.09 | 0.81 |
| EPS Basic Continuous Ops | 0.34 | 0.58 | 0.58 | 2.09 | 0.81 |
| EPS Diluted Total Ops | 0.34 | 0.58 | 0.58 | 2.05 | 0.80 |
| EPS Diluted Continuous Ops | 0.33 | 0.58 | 0.58 | 2.06 | 0.80 |
| EBITDA(a) | $1,983,022 | $2,400,958 | $2,746,604 | $3,037,470 | $3,861,810 |